8225 logo

China Health Group Inc. Stock Price

SEHK:8225 Community·HK$124.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

8225 Share Price Performance

HK$0.13
-0.04 (-21.88%)
HK$0.13
-0.04 (-21.88%)
Price HK$0.13

8225 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

3 Risks
1 Reward

China Health Group Inc. Key Details

CN¥28.6m

Revenue

CN¥12.2m

Cost of Revenue

CN¥16.4m

Gross Profit

CN¥31.4m

Other Expenses

-CN¥15.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.015
57.39%
-52.38%
0%
View Full Analysis

About 8225

Founded
1998
Employees
32
CEO
n/a
WebsiteView website
www.chgi.net

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.

Recent 8225 News & Updates

Recent updates

No updates